Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
April 15, 2024
Adaptation is not a universal response to climate shocks, and while a lot of studies are geared towards building adaptive capacity of households, particularly in developing country settings, more recognition should be given to cultural and religious factors that may significantly mitigate responses.
Blog Post
December 04, 2023
Food insecurity is again a major topic of global concern. Decades of progress are under threat from the effects of climate change on agriculture along with supply chain dislocations linked to the pandemic and Russia’s invasion of Ukraine. An estimated 333 million people worldwide are now experiencin...
Blog Post
November 09, 2023
There are so many studies regarding so many aspects of development economics that it can be difficult to keep up. Last week was the North East Universities Development Consortium annual conference, often called NEUDC. Researchers presented more than 130 papers across a wide range of topics, from agr...
WORKING PAPERS
August 29, 2023
The war in Ukraine was associated with large changes in the prices of key food and fuel commodities in 2022 which produced macroeconomic gains for exporters and losses as import costs increased. Across 49 countries benefitting, these gains averaged about 8 percent of GDP and reach up to 36 percent o...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.